NCT03190824 2019-04-16Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic MelanomaSyneos HealthPhase 2 Unknown4 enrolled
NCT00116363 2008-04-01Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit MelanomaIntrogen TherapeuticsPhase 2 Unknown25 enrolled